Search Results 651-660 of 17853 for Assay

1. Tumor-informed ctDNA reshapes care in urothelial carcinoma - Mayo Clinic

   With the advent of next-generation sequencing, researchers can now design personalized assays to identify and track tumor-informed mutations in the bloodstream.

2. Focus Areas - Department of Quantitative Health Sciences - Mayo Clinic Research

   Recent advances have enabled application of technologies such as assay for transposase-accessible chromatin sequencing (ATAC-seq) and RNA sequencing (RNA-seq) ...

3. Ampullary Cancer Clinical Trials - Mayo Clinic Research

   GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...

4. Pediatrics Clinical Trials - Medical Professionals

   This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

5. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation For Children, Adolescents, And Young Adults With Acute Leukemia Or Myelodysplastic Syndrome - Mayo Clinic

   - If a screening assay against pooled HLA antigens is used, positive results ... concentration on the single antigen assays. Donor anti- recipient

6. Diabetic Nephropathy Clinical Trials - Mayo Clinic Research

   The purpose of this study is to evaluate the Renasight™ test, a next generation sequencing (NGS) gene mutation assay, for patients with chronic kidney ...

7. Mayo Clinic researchers identify a measurable genetic mutation as a significant predictor of metastasis and survival in pancreatic cancer

   Thus, the study suggests that ctDNA assays should be performed prior to treatment to have the highest yield. The researchers examined data between 2018 and ...

8. Clinical trials - Oncology (Medical)

   cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

9. Adam M. Kase - Doctors and Medical Staff - Mayo Clinic

   He is engaged in clinical trials and translational research including patient-derived tumor xenograft models and high-throughput drug assays using 3D spheroids ...

10. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

    ... assay at any time prior to Screening or by the central laboratory. Notes: Only PCR and NGS-based local assays results will be acceptable;; Central testing ...